title: Low molecular weight heparin: a practical approach in deep venous thrombosis in palliative care.
abstract: BACKGROUND
  Deep vein thrombosis (DVT) is one of the many cause of pain in advance cases of carcinoma cervix. The most widely used agent for combating DVT is unfractionated heparin.
  
  
  OBJECTIVE
  Aims of this study is to see the efficacy of the use of low molecular weight (LMW) haparin and its practical utility in palliative care settings.
  
  
  METHODS
  Twelve cases of established DVT received enoxaparin at 40 mg/m with warfarin.
  
  
  RESULTS
  There was 70% resolution of limb swelling in seven cases. Out of remaining four cases took two months to resolve and one case did not resolve completely.
  
  
  CONCLUSIONS
  LMV heparin is effective in palliative care setting and also has added advantage of subcutaneous route of administration.
authors: Department of Radiotherapy, Medical College and Hospital, Kolkata, India.
authors: Samrat
authors: S
authors: Dutta
authors: Subrata
authors: S
authors: Chattopadhayay
authors: C
authors: C
authors: Dasgupta
authors: Shyamal
authors: S
authors: Sarkar